biomarker 986 words KG: BIOMARKER
Contents

FABP3 (Fatty Acid Binding Protein 3) - Biomarker

🔬 Protein Info
Gene SymbolBIOMARKER
FunctionBinds long-chain fatty acids, retinoic acid, and other lipids
Primary ExpressionHeart, skeletal muscle, brain (neurons), kidney
StructureBeta-barrel structure with hydrophobic core
Primary expressionNeurons (pyramidal cells, Purkinje cells)
Regional distributionHigh in cortex, hippocampus, cerebellum
Function in brainLipid transport, synaptic plasticity, neuroprotection
Necrosiscell membrane rupture
Apoptosiscontrolled release from dying cells
Exocytosisactive release under certain conditions
Membrane permeabilityincreased permeability during injury
Correlates with cognitive declinehigher levels = worse performance
Predicts progressionhigh baseline predicts MCI→AD conversion
Combined with other biomarkersenhances diagnostic accuracy
Elevated in early PDpotential early marker
Correlates with motor severityUPDRS scores
KG Connections1 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Related Hypotheses (9)

Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.92
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.76
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.72
Membrane Cholesterol Gradient Modulators
Score: 0.71

Related Analyses (7)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived

Related Experiments (14)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40

Knowledge Graph (1 edges)

NEUROPROTEOMICS identifies BIOMARKER

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)